| Effects of fish oil hepatic peroxidation in rats and antioxidant role of vitamin E | Naime CANORUÇ,Nihat GÜRKAN,NURİYE METE,Aydın KETANİ,Fikri CANORUÇ | 181–184 |
| Combination therapy with lamivudine and low dose hepatitis-B immune globulin against hepatitis-B recurrence after liver transplantation | Fulya GÜNŞAR,Yaman TOKAT,Zeki KARASU,Ulus S. AKARCA,Tijen ÖZACAR,Gül YÜCE | 185–190 |
| Daily use of consensus interferon: One-year treatment results for chronic hepatitis C patients relapsing or non-responding to previous interferon | Zeki KARASU,Ahmet GÜRAKAR,Ahmad JAZZAR,Harlan WRIGHT | 191–195 |
| L-Carnitine therapy in non-alcoholic steatohepatitis | Ahmet UYGUN,Abdurrahman KADAYIFÇI,Sait BAĞCI,Ahmet ERDİL,Salih DEVECİ,MENDANE SAKA,Yüksel ATEŞ,Fatih BULUCU,Necmettin KARAEREN,Kemal DAĞALP | 196–201 |
| Effect of eradication of Helicobacter pylori on the quality of duodenal ulcer healing | Melih ÖZEL,YUSUF YAZGAN,Ahmet K. GÜRBÜZ,Levent DEMİRTÜRK,Şükrü YILDIRIM,Alp GÜNAY,Ramazan ÖZTÜRK,Orhan TARÇIN | 202–207 |
| Systemic cellular immune response in Helicobacter pylori associated duodenal ulcer and chronic antral gastritis | Hakan YÜCEYAR,Murat SARUÇ,Ali KOKULUDAĞ,Ender TERZİOĞLU,Gamze GÖKSEL,Aydın İŞİSAĞ | 208–211 |
| Re-bleeding in patients following Helicobacter pylori eradication therapy for bleeding peptic ulcer: Results of 18 month-follow up | LEVENT KAMİL ERDEM,Sadık YILDIRIM,Ayşim SUNGÜN,Fatih BEŞIŞIK | 212–215 |
| The effects of alcohol on gastric mucosa and gastric emptying time | Tülay SARIÇAM,Osman SON,Sare KABUKÇUOĞLU,Yurdanur AKGÜN,İlknur AK,Eser VARDARELİ | 216–221 |
| Factors affecting healing of enterocutaneous fistulas | Tarık Z. NURSAL,Ataç BAYKAL,Hasan ALTUN,Ömer ARAN | 222–226 |
| A retrospective trial comparing 5-ASA plus ciprofloxacin and metronidazole with 5-ASA and corticosteroids in the treatment of active Crohn's disease | Erkan PARLAK,Aysel ÜLKER,Ülkü DAĞLI,Canan ALKIM | 227–230 |
| A retrospective trial comparing 5-ASA plus ciprofloxacin and metronidazole with 5-ASA and corticosteroids in the treatment of active Crohn's disease |